<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00611169</url>
  </required_header>
  <id_info>
    <org_study_id>2005-09-007-001</org_study_id>
    <nct_id>NCT00611169</nct_id>
  </id_info>
  <brief_title>The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction</brief_title>
  <official_title>The Effects of Facilitated Percutaeous Coronary Intervention Compared to Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Acute Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study to investigate whether the administration of high-dose tirofiban
      before primary PCI could reduce myocardial infarct size, using analysis of contrast-enhanced
      magnetic resonance imaging.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2006</start_date>
  <completion_date type="Actual">August 2007</completion_date>
  <primary_completion_date type="Actual">February 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Infarct size and its transmural extent using MRI</measure>
    <time_frame>within the first 30 days after index procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>pre-PCI thrombolysis in myocardial infarction grade, post-PCI myocardial blush grade, ST-segment resolution on electrocardiography, and left ventricular ejection fraction on echocardiography</measure>
    <time_frame>at 6 month after index procedure</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Acute Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Aspirin, clopidogrel, unfractionated heparin plus tirofiban infusion at high bolus dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Aspirin, clopidogrel, unfractionated heparin</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tirofiban</intervention_name>
    <description>tirofiban (25 μg/kg bolus and 0.15 μg/kg/min maintenance infusion for 24 hours)</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  presence of chest pain for more than 30 minutes but less than 12 hours after symptom
             onset

          -  ST-segment elevation more than 1 mm in two or more contiguous leads or presumably a
             new-onset left bundle branch blockage

        Exclusion Criteria:

          -  hemodynamic instability

          -  history of MI

          -  old age &gt; 80years

          -  Patients with bleeding diathesis (coagulopathy, thrombocytopenia or platelet
             dysfunction, Gastrointestinal or genitourinary bleeding within the prior 3 months)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hyeon-Cheol Gwon, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samsung Medical Center</affiliation>
  </overall_official>
  <verification_date>August 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 27, 2008</study_first_submitted>
  <study_first_submitted_qc>February 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2008</study_first_posted>
  <last_update_submitted>February 7, 2008</last_update_submitted>
  <last_update_submitted_qc>February 7, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 8, 2008</last_update_posted>
  <responsible_party>
    <name_title>HC Gwon</name_title>
    <organization>Samsung Medical Center</organization>
  </responsible_party>
  <keyword>Angioplasty, Transluminal, Percutaneous Coronary</keyword>
  <keyword>tirofiban</keyword>
  <keyword>Magnetic Resonance Imaging</keyword>
  <keyword>Myocardial Infarction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tirofiban</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

